The CD79a Rabbit Monoclonal Antibody is a high-affinity recombinant antibody engineered for precise detection of CD79a, a critical component of the B-cell receptor (BCR) complex. Expressed throughout most stages of B-cell development—from early precursor B cells to plasma cells—CD79a serves as a key biomarker for identifying B-cell lineage in both normal and neoplastic tissues. This rabbit monoclonal antibody offers enhanced sensitivity and specificity over conventional mouse monoclonals, providing crisp, membranous and cytoplasmic staining with minimal background. Optimized for use in immunohistochemistry (IHC) on formalin-fixed, paraffin-embedded (FFPE) tissues, the antibody is also suitable for flow cytometry (FC) and Western blot (WB), making it an essential tool for research and clinical diagnostics. CD79a is widely used in the diagnosis of B-cell lymphomas, acute lymphoblastic leukemia (ALL), and other hematolymphoid malignancies. It is especially valuable in cases where CD20 expression is diminished or absent, enabling reliable identification of B-cell lineage in challenging diagnostic settings. Manufactured using recombinant antibody technology and purified through affinity chromatography, the CD79a Rabbit Monoclonal Antibody ensures lot-to-lot consistency, stability, and reproducible results in a wide range of laboratory workflows. Key Features: Target: CD79a (Ig-alpha component of the BCR complex) Clone: Rabbit Monoclonal (specific clone info can be added if needed) Host / Isotype: Rabbit / IgG Reactivity: Human Applications: Immunohistochemistry (IHC), Flow Cytometry (FC), Western Blot (WB) Sample Types: FFPE tissues, frozen sections, cell lysates Purification: Affinity-purified Storage: Store at −20°C; avoid freeze-thaw cycles Applications in Research & Diagnostics: Immunophenotyping of B-cell populations Diagnosis of B-cell lymphomas and leukemias Differentiation between T-cell and B-cell neoplasms Investigation of B-cell maturation and signaling pathways Translational research in hematopathology and oncology
GRM297
GRM297 reacts to human CD79a
A peptide corresponding to the C-terminus of human CD79a
Immunohistochemistry (IHC) Western Blot (WB)
Human
None
Research Use Only
Stable for 1 Year at -20.0°C from date of receipt.
At Genebiosolution, our commitment lies in crafting cutting-edge solutions for researchers, clinicians, and diagnostic laboratories seeking excellence in immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). With a focus on quality, reliability, and accuracy, our products empower advancements in molecular diagnostics and research methodologies.
